Diagnostic and Prognostic Utility of Plasma microRNA Signatures in Patients with Myelodysplastic Syndromes

被引：0
|
作者：
Loghavi, S. [1 ]
Bueso-Ramos, C. E. [1 ]
Maiti, S. N. [1 ]
Hu, S. [1 ]
Calin, G. A. [1 ]
Garcia-Manero, G. [1 ]
Kantarjian, H. M. [1 ]
Medeiros, J. [1 ]
Cooper, L. [1 ]
Zuo, Z. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1479
引用
收藏
页码：359A / 359A
页数：1
相关论文
共 50 条
  • [1] Diagnostic and Prognostic Utility of Plasma microRNA Signatures in Patients with Myelodysplastic Syndromes
    Loghavi, S.
    Bueso-Ramos, C. E.
    Maiti, S. N.
    Hu, S.
    Calin, G. A.
    Garcia-Manero, G.
    Kantarjian, H. M.
    Medeiros, J.
    Cooper, L.
    Zuo, Z.
    LABORATORY INVESTIGATION, 2014, 94 : 359A - 359A
  • [2] Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes
    Aanei, Carmen Mariana
    Picot, Tiphanie
    Tavernier, Emmanuelle
    Guyotat, Denis
    Catafal, Lydia Campos
    FRONTIERS IN ONCOLOGY, 2016, 6
  • [3] MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes
    Choi, Ji-Seon
    Nam, Myung-Hyun
    Yoon, Soo-Young
    Kang, Seong-Ho
    LEUKEMIA RESEARCH, 2015, 39 (07) : 763 - 768
  • [4] The utility of fish technology as diagnostic tool in myelodysplastic syndromes
    Pisano, M.
    De Filippi, A.
    Greco, L.
    Vergara, D.
    Valacca, A.
    Leo, G.
    ANNALS OF ONCOLOGY, 2007, 18 : 56 - 56
  • [5] Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.
    Della Porta, Matteo G.
    Picone, Cristina
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2017, 9
  • [6] Association of metabolic signatures in plasma and urine in patients with myelodysplastic syndromes - a pilot study
    Balaian, E.
    Sockel, K.
    Wobus, M.
    Oelschlaegel, U.
    Bornhaeuser, M.
    Chavakis, T.
    Funk, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 132 - 132
  • [7] The Diagnostic Utility of a Myeloid Mutational Panel for Myelodysplastic Syndromes and Myelodysplastic/myeloproliferative Neoplasms
    Ibrar, Warda
    Cox, Jesse
    Amador, Catalina
    Qureishi, Hina
    Fu, Kai
    Greiner, Timothy
    Vokoun, Allison
    Zhang, Weiwei
    Ji, Yuan
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1310 - 1310
  • [8] The Diagnostic Utility of a Myeloid Mutational Panel for Myelodysplastic Syndromes and Myelodysplastic/myeloproliferative Neoplasms
    Ibrar, Warda
    Cox, Jesse
    Amador, Catalina
    Qureishi, Hina
    Fu, Kai
    Greiner, Timothy
    Vokoun, Allison
    Zhang, Weiwei
    Ji, Yuan
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1310 - 1310
  • [9] Epigenetic signatures as prognostic tools in acute myeloid leukemia and myelodysplastic syndromes
    Christopeit, Maximilian
    Bartholdy, Boris
    EPIGENOMICS, 2014, 6 (04) : 371 - 374
  • [10] Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact
    Oelschlaegel, Uta
    Oelschlaeger, Lorenz
    von Bonin, Malte
    Kramer, Michael
    Sockel, Katja
    Mohr, Brigitte
    Wagenfuehr, Lisa
    Kroschinsky, Frank
    Bornhaeuser, Martin
    Platzbecker, Uwe
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (02) : 141 - 150
12345